Showing 1381-1390 of 1498 results for "".
- New AAFPRS Data: More Than 30 Percent of Men Are Considering Nips and Tuckshttps://modernaesthetics.com/news/new-aafprs-data-more-than-30-percent-of-men-are-considering-nips-and-tucks/2472223/The plastic surgery ‘menaissaince’ may really be a thing, finds a new survey from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). It turns out that 31 percent of men said they are “extremely likely&rdq
- NJ Plastic Surgeon Dr. Barry Dibernardo To Lead ASERFhttps://modernaesthetics.com/news/nj-plastic-surgeon-barry-dibernardo-md-to-lead-aserf/2472233/New Jersey-based plastic surgeon Barry Dibernardo, MD is the new President of the Aesthetic Surgery Education And Research Foundation. ASERF is the philanthropic research and education arm of the American Society fo
- Plastic Surgeons Offer Video Tips To Maximize Safety During Filler Injectionshttps://modernaesthetics.com/news/plastic-surgeons-offer-tips-to-maximize-safety-during-filler-injections/2472236/Avoiding key "danger zones" may help plastic surgeons enhance the safety and effectiveness of facial filler procedures, according to an expert update in the May issue of Plastic and Reconstructive Surgery®. The article out
- ThermiGen, an Almirall company, Names Vladimir Paul-Blanc President & General Managerhttps://modernaesthetics.com/news/thermigen-an-almirall-company-names-vladimir-paul-blanc-president-general-manager/2472245/Vladimir Paul-Blanc has been named President & General Manager of ThermiGen, LLC, starting May 1. He will report directly to the Executive Vice-president of Commercial Strategy of Almirall, Alfonso Ugarte, and he will be responsible for all general management responsibilities for the Thermi b
- ASPS: More than $16 Billion Spent on Cosmetic Plastic Surgery in 2016https://modernaesthetics.com/news/asps-more-than-16-billion-spent-on-cosmetic-plastic-surgery-in-2016/2472246/Americans spent more than ever before – $16 billion – on cosmetic plastic surgery and minimally-invasive procedures in 2016, according to a new report from the American Society of Plastic Surgeons (ASPS). The new report also breaks
- Restylane® Refyne and Restylane® Defyne Show Lasting Natural Benefit in Phase 4 Studieshttps://modernaesthetics.com/news/restylane-refyne-and-restylane-defyne-show-lasting-natural-benefit-in-phase-4-studies/2472251/Two Phase 4 clinical studies of Restylane® Refyne and Restylane® Defyne show that the natural-looking results last. Specifically, the Natural Expression study found that naturalness in facial expressions was at least main
- Galderma Rolls Out Restylane Refyne, Defynehttps://modernaesthetics.com/news/galderma-rolls-out-restylane-refyne-defyne/2472262/With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --
- Galderma, Colorescience to Collaborate on Innovative Skincarehttps://modernaesthetics.com/news/galderma-colorescience-to-collaborate-on-innovative-skincare/2472266/Galderma will collaborate with Colorescience to expand skincare solutions to individuals who seek innovative daily skincare products that can be used in conjunction with traditional facial injectable aesthetic treatments, the companies have announced. Galderma and
- In a Week of Surprising Acquisitions, Will Syneron Be Next?https://modernaesthetics.com/news/in-a-week-of-surprising-acquisitions-will-syneron-be-next/2472276/Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners is looking to buy Syneron Medical for $350-$400 million. According to Israeli finan
- Cynosure to Be Acquired by Hologichttps://modernaesthetics.com/news/cynosure-to-be-acquired-by-hologic/2472278/Hologic, Inc. and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65 billion